News | Page 41 | Englander Institute for Precision Medicine

EIPM Researchers Earn Cancer Grand Challenges Funding Award to Study Cancer Inequity

March 6, 2024

Weill Cornell Medicine is part of an international team that has been awarded funding of up to $25 million over five years by Cancer Grand Challenges to study the causes of cancer inequities.

Cancer Grand Challenges is a global funding initiative co-founded by the...

Male breast cancer represents less than 1 percent of all breast cancer cases each year. Unlike breast cancer in women, survival rates for men haven't significantly improved in the last 30 years, according to the National Cancer Institute. Credit: iStock

Deciphering the Male Breast Cancer Genome

March 5, 2024

Male breast cancer has distinct alterations in the tumor genome that may suggest potential treatment targets, according to a study by Weill Cornell Medicine investigators. They have conducted the first whole genome sequencing analysis of male breast cancer, which looked at the complete DNA landscape of tumor samples from 10 patients.

This is an important...

Oncologist Receives Prestigious MERIT Grant from the National Cancer Institute for Bladder Cancer Research

March 4, 2024

Bishoy M. Faltas, MD, a medical oncologist at NewYork-Presbyterian/Weill Cornell Medicine and Director of Bladder Cancer Research at the Englander Institute for Precision Medicine at Weill Cornell Medicine, was awarded a MERIT grant from the National Cancer Institute at the National Institutes of Health to advance his research into the role of...